Jim Cramer Recommends This Energy Stock, But Don't 'Bank It All' On Arcus

Group 1 - Jim Cramer recommended buying Uranium Energy Corp (UEC), expressing a positive outlook on nuclear energy [1] - HC Wainwright & Co. analyst Heiko F. Ihle maintained a Buy rating for Uranium Energy and raised the price target from $12.25 to $12.75 [1] - Arcus Biosciences, Inc. (RCUS) was described as a speculative investment by Cramer, advising caution and diversification in investment strategy [2] - Wells Fargo analyst Eva Fortea Verdejo maintained an Overweight rating for Arcus Biosciences but lowered the price target from $26 to $25 [2] Group 2 - Arcus Biosciences shares increased by 4% to close at $10.06 [4] - Uranium Energy shares decreased by 1.1% to close at $10.22 [4]